Key result
This editorial reviews recent heart failure research, including findings that renin-angiotensin inhibitors are associated with reduced mortality (HR 0.78) in HFrEF patients over 80 years old.
Design
Editorial
Authors
Loading...
May inform individualized HFrEF therapy in octogenarians; leaves open need for dedicated RCTs.
This editorial provides an overview of multiple articles in the issue focusing on personalized approaches to heart failure, including the impact of age, comorbidities like diabetes and atrial fibrillation, and novel therapeutic strategies.
Thomas F. Lüscher (2018) conducted an editorial in Heart failure. This editorial reviews recent heart failure research, including findings that renin-angiotensin inhibitors are associated with reduced mortality (HR 0.78) in HFrEF patients over 80 years old.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: